Hepatic T1-time predicts cardiovascular risk in all-comers referred for cardiovascular magnetic resonance.

26 August 2022 (14:15 - 15:00)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor Katharina Mascherbauer

Medical University of Vienna, Vienna (Austria)

7 More presentations in this session

Presentation thumbnail

Investigating myocardial energetic deficit across the spectrum of cardiac disease

Doctor A. Henry (Oxford, GB)

Abstract Slides

Presentation thumbnail

Prognostic implications of trabecular complexity measured by fractal analysis in left ventricular noncompaction

Miss A. Romero Valero (Elche, ES)

Abstract Slides

Presentation thumbnail

Unmasking systolic impairment in HFpEF by cardiovascular magnetic resonance derived hemodynamic force assessment: Insights from the HFpEF stress trial

Doctor S. Backhaus (Bad Nauheim, DE)

Abstract Slides

Presentation thumbnail

Ratio between left and right ventricular end-diastolic volumes and outcomes in patients with heart failure and preserved ejection fraction

Doctor A. Aimo (Pisa, IT)

Abstract Slides

Presentation thumbnail

A phase 2a trial investigating ninerafaxstat - a novel cardiac mitotrope for the treatment of diabetic cardiomyopathy (IMPROVE-DiCE)

Doctor M. Hundertmark (Bern, CH)

Abstract Slides

Access the full session

Session thumbnail

CMR in the evaluation of cardiomyopathies and heart failure

The Event

Event poster

ESC Congress 2022

26 August 2022 14:15 CET

You may be interested in

Congress Presentation

How to do parametric mapping

Congress Presentation

T1rho and T2rho based myocardial tissue characterisation in small animals at high-field MRI

Congress Presentation

New guidelines in pericardial diseases: what is the role of multimodality imaging? - discussion

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources